famotidine has been researched along with ibuprofen in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (28.57) | 29.6817 |
2010's | 28 (66.67) | 24.3611 |
2020's | 2 (4.76) | 2.80 |
Authors | Studies |
---|---|
Hariganesh, K; Prathiba, J | 1 |
Bhilegaonkar, PM; Kiran Babu, S; Shirwaikar, A; Sridhar Reddy, B; Sudheer Kumar, M; Unnikrishnan, MK | 1 |
Birk, JW; Myers, M | 1 |
Peura, D; Schiff, M | 1 |
Bello, AE; Grahn, AY; Kivitz, AJ; Laine, L; Schiff, MH; Taha, AS | 1 |
Chan, FK | 1 |
Holt, RJ; Johnson, KE; Kent, JD; Kuan, R; Malone, D; Peura, DA | 1 |
Deeks, ED | 1 |
Burks, AW; Land, MH; Piehl, MD | 1 |
Peura, D; Tuskey, A | 1 |
Itai, S; Iwao, Y; Kimura, S; Noguchi, S; Sano, S | 1 |
Bello, AE; Grahn, AY; Holt, RJ; Kent, JD; Rice, P | 1 |
El-Kimary, EI; Ragab, MA | 1 |
Ball, J; Bello, AE; Grahn, AY; Holt, RJ; Kent, JD | 2 |
Taha, AS | 1 |
Elzanfaly, ES; Salem, MY; Soudi, AT; Zaazaa, HE | 3 |
Bello, AE; Holt, RJ; Kent, JD | 1 |
Baldoni, HA; Brusau, EV; Dávila, YA; Ellena, JA; Narda, GE; Russo, MG | 1 |
Dressman, J; Litou, C; Psachoulias, D; Reppas, C; Vertzoni, M | 1 |
Habara, M; Haraguchi, T; Ikezaki, H; Kawasaki, I; Kojima, H; Ohkawa, K; Ozeki, M; Uchida, T; Uno, R; Yoshida, M | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Kobayashi, Y; Kohyama, N; Ohbayashi, M; Ohshiro, N; Tsuchiya, A; Yamamoto, T | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
5 review(s) available for famotidine and ibuprofen
Article | Year |
---|---|
HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Famotidine; Female; Gastrointestinal Diseases; Gastrointestinal Tract; Histamine H2 Antagonists; Humans; Ibuprofen; Male; Osteoarthritis | 2012 |
Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Drug Interactions; Duodenal Ulcer; Famotidine; Histamine H2 Antagonists; Humans; Ibuprofen; Stomach Ulcer | 2013 |
The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Therapy, Combination; Famotidine; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Ibuprofen; Intestinal Mucosa; Stomach Ulcer | 2013 |
Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Combinations; Duodenal Ulcer; Famotidine; Female; Humans; Ibuprofen; Incidence; Male; Middle Aged; Osteoarthritis; Randomized Controlled Trials as Topic; Stomach Ulcer; Tablets | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for famotidine and ibuprofen
Article | Year |
---|---|
Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Chi-Square Distribution; Double-Blind Method; Drug Combinations; Duodenal Ulcer; Endoscopy, Gastrointestinal; Famotidine; Female; Humans; Ibuprofen; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Stomach Ulcer; Treatment Outcome | 2012 |
One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Combinations; Drug Monitoring; Dyspepsia; Endoscopy, Gastrointestinal; Famotidine; Female; Histamine H2 Antagonists; Humans; Ibuprofen; Incidence; Male; Middle Aged; Patient Compliance; Severity of Illness Index; Stomach Ulcer; Treatment Outcome | 2015 |
One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Combinations; Drug Monitoring; Dyspepsia; Endoscopy, Gastrointestinal; Famotidine; Female; Histamine H2 Antagonists; Humans; Hypertension; Ibuprofen; Incidence; Male; Middle Aged; Patient Compliance; Severity of Illness Index; Stomach Ulcer; Treatment Outcome | 2015 |
Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Combinations; Duodenal Ulcer; Famotidine; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Male; Middle Aged; Osteoarthritis; Risk Factors; Stomach Ulcer; Tablets; United States | 2015 |
33 other study(ies) available for famotidine and ibuprofen
Article | Year |
---|---|
Effect of dimethylglycine on gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Famotidine; Gastric Juice; Glutathione; Hydrogen-Ion Concentration; Ibuprofen; Ligation; Malondialdehyde; Pylorus; Rats; Rats, Wistar; Sarcosine; Severity of Illness Index; Stomach Ulcer; Stress, Physiological | 2000 |
Antiinflammatory and antiulcer activities of phytic acid in rats.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Cold Temperature; Ethanol; Famotidine; Gastric Mucosa; Hemorrhage; Ibuprofen; Malondialdehyde; Necrosis; Phytic Acid; Plant Extracts; Rats; Stomach Ulcer; Stress, Physiological; Sulfhydryl Compounds | 2004 |
A fixed dose combination of ibuprofen and famotidine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Famotidine; Gastrointestinal Diseases; Humans; Ibuprofen; Pain | 2009 |
A fixed-dose combination ibuprofen and famotidine (Duexis).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Combinations; Duodenal Ulcer; Famotidine; Histamine H2 Antagonists; Humans; Ibuprofen; Osteoarthritis; Stomach Ulcer | 2011 |
Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Female; Humans; Ibuprofen; Male; Stomach Ulcer | 2012 |
Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Drug Combinations; Drug Costs; Famotidine; Humans; Ibuprofen; Models, Economic; Osteoarthritis; Patient Compliance; Stomach Ulcer; Tablets | 2013 |
Near fatal anaphylaxis from orally administered gelatin capsule.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Anaphylaxis; Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Child; Diphenhydramine; Epinephrine; Famotidine; Female; Follow-Up Studies; Gelatin; Histamine H2 Antagonists; Humans; Ibuprofen; Prednisone; Treatment Outcome | 2013 |
Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
Topics: Acetaminophen; Administration, Oral; Drug Stability; Famotidine; Hardness; Ibuprofen; Kinetics; Microwaves; Solubility; Tablets; Technology, Pharmaceutical; Transition Temperature; Water | 2014 |
Derivative emission spectrofluorimetry: Application to the analysis of newly approved FDA combination of ibuprofen and famotidine in tablets.
Topics: Calibration; Drug Combinations; Famotidine; Hydrogen-Ion Concentration; Ibuprofen; Limit of Detection; Reproducibility of Results; Sensitivity and Specificity; Solvents; Spectrometry, Fluorescence; Tablets | 2015 |
The ibuprofen-famotidine combined pill - a promise fulfilled.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dyspepsia; Famotidine; Female; Histamine H2 Antagonists; Humans; Hypertension; Ibuprofen; Male; Stomach Ulcer | 2015 |
Application of the ratio difference spectrophotometry to the determination of ibuprofen and famotidine in their combined dosage form: comparison with previously published spectrophotometric methods.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Famotidine; Ibuprofen; Spectrophotometry, Ultraviolet | 2015 |
Development and validation of chromatographic methods for simultaneous determination of ibuprofen and famotidine in presence of related substances in pharmaceutical formulations.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Famotidine; Ibuprofen; Molecular Structure | 2015 |
Multivariate Validated Models for Simultaneous Determination of Ibuprofen and Famotidine in the Presence of Related Substances.
Topics: Calibration; Drug Contamination; Famotidine; Ibuprofen; Least-Squares Analysis; Limit of Detection; Models, Statistical; Multivariate Analysis; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets | 2018 |
Rational Design of a Famotidine-Ibuprofen Coamorphous System: An Experimental and Theoretical Study.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Density Functional Theory; Drug Compounding; Drug Design; Famotidine; Hydrogen Bonding; Ibuprofen; Models, Chemical; Molecular Dynamics Simulation; Molecular Structure; Spectroscopy, Fourier Transform Infrared | 2018 |
Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.
Topics: Bicarbonates; Bile Acids and Salts; Body Fluids; Buffers; Famotidine; Gastrointestinal Absorption; Humans; Hydrogen-Ion Concentration; Ibuprofen; Intestine, Small; Salts; Stomach; Upper Gastrointestinal Tract | 2020 |
Masking the Taste of Fixed-Dose Combination Drugs: Particular NSAIDs Can Efficiently Mask the Bitterness of Famotidine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Famotidine; Flurbiprofen; Ibuprofen; Naproxen; Taste | 2023 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3.
Topics: Allopurinol; Animals; Biological Transport; Dose-Response Relationship, Drug; Female; Kidney; Male; Mice; Oocytes; Organic Anion Transporters, Sodium-Independent; Substrate Specificity; Xenopus laevis | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |